NCT04099446 A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer Status WITHDRAWN Phase N/A
NCT04093401 The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated. Status WITHDRAWN Phase NA
NCT04066504 Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma Status COMPLETED Phase N/A
NCT03982212 A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors Status UNKNOWN Phase PHASE1
NCT03972748 Use Of Oral Itraconazole In Patients With Locally Limited Basocellular Carcinoma Of Skin. Status UNKNOWN Phase NA
NCT03889912 Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma Status COMPLETED Phase PHASE1
NCT03848078 (Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC) Status UNKNOWN Phase NA
NCT03775525 Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer Status UNKNOWN Phase PHASE1
NCT03734913 A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors Status UNKNOWN Phase PHASE1
NCT03714529 A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT03646188 Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) Status TERMINATED Phase PHASE1
NCT03610620 Confocal Microscopy Evaluation of Margin Clearance in Basal Cell Carcinomas in Mohs Surgery Status COMPLETED Phase NA
NCT03534947 A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT03521830 Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma Status RECRUITING Phase PHASE2
NCT03517488 A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors Status COMPLETED Phase PHASE1